3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Sue Yom: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) Nivolumab, Cisplatin, Radiation Therapy - Nasopharyngeal Carcinoma | Phase 2 | Completed | Sue Yom | 40 | 2018-02-14 | 2026-01-12 |
| Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer Pembrolizumab, stereotactic radiation therapy (SRT), Surgery (Non-interventional, standard of care) - Non Small Cell Lung Cancer | Phase 2 | Completed | Sue Yom | 12 | 2017-10-04 | 2024-10-23 |
| Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma Vismodegib, Radiation therapy - Locally Advanced Basal Cell Carcinoma, Skin Cancer | Phase 2 | Completed | Sue Yom | 24 | 2013-05-01 | 2021-05-03 |
Carcinoma, Non-Small-Cell Lung (1) · Head and Neck Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Skin Neoplasms (1)
Radiotherapy (2) · Cisplatin (1) · HhAntag691 (1) · Nivolumab (1) · Radiosurgery (1) · Standard of Care (1) · Surgical Procedures, Operative (1) · pembrolizumab (1)
United States (3) · Singapore (1)